348 related articles for article (PubMed ID: 25732226)
1. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
4. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
5. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
7. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
8. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
9. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression.
Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X
FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796
[TBL] [Abstract][Full Text] [Related]
11. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
[TBL] [Abstract][Full Text] [Related]
12. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.
Xiang M; Birkbak NJ; Vafaizadeh V; Walker SR; Yeh JE; Liu S; Kroll Y; Boldin M; Taganov K; Groner B; Richardson AL; Frank DA
Sci Signal; 2014 Jan; 7(310):ra11. PubMed ID: 24473196
[TBL] [Abstract][Full Text] [Related]
13. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
14. MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.
Li D; Song H; Wu T; Xie D; Hu J; Zhao J; Shen Q; Fang L
Mol Cell Biochem; 2018 Jul; 444(1-2):169-178. PubMed ID: 29188531
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
Tang Z; Fang Y; Du R
Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
[TBL] [Abstract][Full Text] [Related]
17. Aspongopus chinensis ach-miR-276a-3p induces breast cancer cell cycle arrest by targeting APPL2 to regulate the CDK2-Rb-E2F1 signaling pathway.
Cai R; Khan S; Chen X; Li H; Tan J; Tian Y; Zhao S; Yin Z; Liu T; Jin D; Guo J
Toxicol Appl Pharmacol; 2024 Mar; 484():116877. PubMed ID: 38431228
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of microRNA-874 represses epithelial mesenchymal transition through the NF-κB pathway via CCNE1 in cholangiocarcinoma.
Pan X; Wang G; Wang B
Cell Signal; 2021 Jun; 82():109927. PubMed ID: 33476715
[TBL] [Abstract][Full Text] [Related]
19. MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-κB Signaling Pathway.
Gao XZ; Zhang ZX; Han GL
J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105210. PubMed ID: 33066952
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
